Publication: Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay
Issued Date
2016-11-01
Resource Type
ISSN
18781810
19315244
19315244
Other identifier(s)
2-s2.0-84979681515
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Translational Research. Vol.177, (2016), 19-30.e5
Suggested Citation
Maciej W. Garbowski, Yongmin Ma, Suthat Fucharoen, Somdet Srichairatanakool, Robert Hider, John B. Porter Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay. Translational Research. Vol.177, (2016), 19-30.e5. doi:10.1016/j.trsl.2016.05.005 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41061
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay
Abstract
© 2016 The Authors Nontransferrin-bound iron (NTBI) is a heterogeneously speciated plasma iron, typically detectable when transferrin saturation (TfSat) exceeds 75%. Here, we examine factors affecting NTBI levels by a recently discovered direct chelator-based (CP851) fluorescent bead-linked flow-cytometric assay (bead-NTBI), compared with the established indirect nitrilotriacetate (NTA) assay in 122 iron-overloaded patients, including 64 on recent iron chelation therapy and 13 healthy volunteers. Both methods correlated (r = 0.57, P < 0.0001) but with low agreement, attributable to 2 major factors: (1) the NTA method, unlike the bead method, is highly dependent on TfSat, with NTBI under-estimation at low TfSat and over-estimation once Tf is saturated, (2) the bead method detects <3-fold higher values than the NTA assay in patients on recent deferiprone-containing chelation due to greater detection of chelate complexes but lower values for patients on deferasirox. The optimal timing of sample collection relative to chelation dosing requires further study. Patients with splenectomy, high-storage iron, and increased erythropoiesis had greater discrepancy between assays, consistent with differential access by both methods to the NTBI pools associated with these clinical variables. The bead-NTBI assay has advantages over the NTA assay, being less dependent on TfSat, hence of less tendency for false-negative or false-positive values at low and high TfSat, respectively.